Booster shots for people who received Moderna or J&J for their primary series are not supported by data at this time and have not been authorized.
We are offering a third dose of the Moderna vaccine for patients who are moderately or severely immunocompromised at least 28 days after the completion of the initial mRNA COVID-19 vaccine series.
The additional dose should be at least 28 days after completion of the initial series.
The additional dose should be the same vaccine product as the initial two-dose mRNA COVID-19 vaccine series (Pfizer-BioNTech or Moderna). If the mRNA COVID-19 vaccine product given for the first two doses is not available, the other mRNA COVID-19 vaccine product may be administered.
Immunocompromised individuals may discuss with their health care provider whether getting an additional dose is appropriate for them. Individuals can self-attest and receive the additional dose.
Currently, CDC is recommending that moderately to severely immunocompromised people receive an additional dose. This includes people who have:
Been receiving active cancer treatment for tumors or cancers of the blood
Received an organ transplant and are taking medicine to suppress the immune system
Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection
Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
In Stock Now
We have Pfizer, Moderna, and Johnson & Johnson vaccines in stock (as of 09/30/2021).
Teens & Children
Confused about which COVID-19 vaccine is best for your teenager? Pfizer vaccine is the only COVID-19 vaccine approved for those younger than 18 years. Adults 18+ can get Pfizer, Moderna, or Johnson & Johnson.